NCT02839291View on ClinicalTrials.gov

Evaluation of Medical Practice in the Management of Bone Metastases After Injectable Bone Antiresorptive Treatment, and Its Influence on Quality of Life

NAActive, not recruitingINTERVENTIONAL

Enrollment

148

Participants

Timeline

Start Date

June 14, 2016

Primary Completion Date

February 5, 2024

Study Completion Date

January 31, 2025

Conditions

Tumor With Bone Metastasis

Interventions

OTHER

quality of life questionaries

DRUG

intravenous or oral bone antiresorptive treatments

Trial Locations (2)

Unknown

Centre Hospitalier Régional Universitaire de Besançon, Besançon

Hôpital Nord Franche-Comté, Montbéliard

All Listed Sponsors

lead

Centre Hospitalier Universitaire de Besancon

OTHER

NCT02839291 - Evaluation of Medical Practice in the Management of Bone Metastases After Injectable Bone Antiresorptive Treatment, and Its Influence on Quality of Life | Biotech Hunter | Biotech Hunter